Skip to main content

Want a detailed portfolio tracker?

Anebulo Pharmaceuticals, Inc. Common Stock (ANEB) P/E (2021 - 2026)

Anebulo Pharmaceuticals, Inc. Common Stock (ANEB) P/E from May 7, 2021 to Jul 21, 2026. The TTM Anebulo Pharmaceuticals, Inc. Common Stock (ANEB) P/E is -1.54. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Anebulo Pharmaceuticals, Inc. Common Stock (ANEB)

YearP/EChange
2026-1.54-70.30%
2025-5.20-19.40%
2024-6.45+20.75%
2023-5.34-27.79%
2022-7.40+68.71%
2021-4.39N/A

Comparison Anebulo Pharmaceuticals, Inc. Common Stock (ANEB) P/E with competitors

Anebulo Pharmaceuticals, Inc. Common Stock (ANEB) P/E is -1.54.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.11%
NBYStablecoin Development Corp0.00-100.28%
ENLVEnlivex Ltd0.07-104.84%
FGENFibroGen Inc0.24-115.54%
CHRSCoherus Biosciences Inc0.85-154.94%
FBIOFortress Biotech Inc0.95-161.44%
ORMPOramed Pharmaceuticals Inc1.50-197.31%
AGENAgenus Inc3.01-294.85%
INVAInnoviva Inc3.15-304.20%
VXRTVaxart Inc3.55-329.82%
CRMDCorMedix Inc3.63-334.91%
CVACCureVac N.V.4.45-387.82%
GLPGGalapagos NV4.86-414.57%
SRPTSarepta Therapeutics Inc4.88-416.07%
ABEOAbeona Therapeutics Inc5.39-448.80%
ABUSArbutus Biopharma Corp5.60-462.27%
ZVRAZevra Therapeutics Inc5.89-481.15%
SPROSpero Therapeutics Inc6.23-503.24%
CGENCompugen Ltd6.31-508.78%
RIGLRigel Pharmaceuticals6.87-544.91%
SLXNSilexion Therapeutics Corp7.30-572.36%
OMEROmeros Corporation9.26-699.43%
AUPHAurinia Pharmaceuticals Inc9.58-720.55%
PLXProtalix BioTherapeutics Inc10.89-805.10%
ACADAcadia Pharmaceuticals Inc11.73-859.33%
TBPHTheravance Biopharma Inc12.26-893.87%
ADMAAdma Biologics Inc12.42-903.97%
HRMYHarmony Biosciences Holdings Inc13.82-994.75%
SABSSAB Biotherapeutics Inc14.14-1015.21%
NAGENiagen Bioscience Inc14.82-1059.35%
INCYIncyte Corp15.82-1124.38%
REGNRegeneron Pharmaceuticals Inc15.86-1126.59%
PBYIPuma Biotechnology Inc17.32-1221.05%
CPRXCatalyst Pharmaceuticals Inc17.44-1229.06%
EXELExelixis Inc17.54-1235.45%
TGTXTG Therapeutics Inc18.97-1327.90%
MDXGMimedx Group Inc20.55-1430.61%
XOMAXOMA Royalty Corp22.87-1580.99%
ARGXArgen X SE24.30-1673.14%
CTMXCytomX Therapeutics Inc24.82-1707.01%
XOMAOXOMA Royalty Corp25.34-1740.92%
HALOHalozyme Therapeutics Inc25.62-1758.97%
XOMAPXOMA Royalty Corp25.67-1761.98%
VRTXVertex Pharmaceuticals Inc27.99-1912.48%
RPRXRoyalty Pharma plc - Class A28.69-1957.34%
SLNOSoleno Therapeutics Inc29.02-1978.56%
ASNDAscendis Pharma A/S30.09-2047.85%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2554.56%
APLSApellis Pharmaceuticals Inc39.02-2626.38%
BMRNBiomarin Pharmaceutical Inc42.21-2832.95%
KRYSKrystal Biotech Inc45.34-3035.70%
ONCBeiGene Ltd69.54-4602.31%
PHARPharming Group N.V.75.03-4957.44%
TECHBio-Techne Corp101.96-6701.17%
VCELVericel Corp109.92-7216.72%
ALNYAlnylam Pharmaceuticals Inc117.96-7737.50%
GMABGenmab140.29-9182.95%
TLXTelix Pharmaceuticals Ltd162.15-10598.38%
CORTCorcept Therapeutics Inc212.86-13881.20%